Evidence map›Paper›PMID 42190216›Full record

ArticleDermatology practical & conceptual2026

A Comprehensive Evaluation of the Efficacy of Intense Pulsed Light and Neodymium-doped Yttrium Aluminum Garnet Laser Treatments in Nail Psoriasis.

Merve Aygün Alizada, Seher Bostancı, Mehmet Fatih Atak, Banu Farabi, Bengü Nisa Akay

Abstract read
In one paragraph

Article in Dermatology practical & conceptual, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Merve Aygün AlizadaDepartment of Dermatology, Faculty of Medicine, Ankara University, AnkaraTurkey.
Seher BostancıDepartment of Dermatology, Faculty of Medicine, Ankara University, AnkaraTurkey.
Mehmet Fatih AtakDepartment of Dermatology, New York Medical College, New YorkUSA.
Banu FarabiDepartment of Dermatology, New York Medical College, New YorkUSA.
Bengü Nisa AkayDepartment of Dermatology, Faculty of Medicine, Ankara University, AnkaraTurkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionNail psoriasis significantly impairs quality of life and remains therapeutically challenging due to the limited efficacy of treatments.

objectivesTo compare the clinical efficacy and safety of Nd:YAG laser and intense pulsed light (IPL) therapy in nail psoriasis using total and modified NAPSI scores, clinical and dermatoscopic findings.

methodsThis retrospective study evaluated 101 nails from 14 patients treated with either IPL (N=66) or Nd:YAG laser (N=35). Treatments were administered every 4-6 weeks for 2-8 sessions. Nail psoriasis severity was assessed at baseline and at six months using NAPSI, mNAPSI, and dermatoscopic and clinical features.

resultsPL therapy significantly reduced matrix (3.48→1.94), nail bed (3.47→1.33), total NAPSI (6.95→3.27), and mNAPSI (9.21→3.92) scores (P<0.05). Nd:YAG laser treatment also resulted in significant improvements in matrix (3.54→2.20), nail bed (3.77→1.97), total NAPSI (7.31→4.17), and mNAPSI (8.83→5.23) scores (P<0.05). In our cohort, IPL appeared to have a more favorable impact on mNAPSI, pitting, salmon patches, subungual hyperkeratosis, and splinter hemorrhages, while Nd:YAG tended to provide greater improvement in leukonychia (P<0.05). No recurrence or adverse event was observed during the 12-month follow-up period.

conclusionsBoth IPL and Nd:YAG laser therapies are safe and effective options for nail psoriasis. IPL showed superior efficacy in nail bed involvement, whereas Nd:YAG may be preferred for leukonychia. Laser-based treatments are promising alternatives in refractory cases.

Identifiers

PMID42190216
PMCPMC13211931

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.